Changjiang Pharmaceutical Group Co., Ltd.

SZSE:300391 Lagerbericht

Marktkapitalisierung: CN¥2.4b

Changjiang Pharmaceutical Group Vergangene Ertragsentwicklung

Vergangenheit Kriterienprüfungen 0/6

Changjiang Pharmaceutical Group's earnings have been declining at an average annual rate of -8%, while the Auto Components industry saw earnings growing at 9% annually. Revenues have been growing at an average rate of 0.2% per year.

Wichtige Informationen

-8.0%

Wachstumsrate der Gewinne

-7.9%

EPS-Wachstumsrate

Auto Components Wachstum der Industrie3.8%
Wachstumsrate der Einnahmen0.2%
Eigenkapitalrendite-115.3%
Netto-Marge-242.4%
Letzte Ertragsaktualisierung30 Sep 2024

Jüngste Aktualisierungen vergangener Leistungen

Recent updates

Revenues Not Telling The Story For Changjiang Pharmaceutical Group Co., Ltd. (SZSE:300391) After Shares Rise 45%

Sep 30
Revenues Not Telling The Story For Changjiang Pharmaceutical Group Co., Ltd. (SZSE:300391) After Shares Rise 45%

Investors Don't See Light At End Of Changjiang Pharmaceutical Group Co., Ltd.'s (SZSE:300391) Tunnel And Push Stock Down 31%

Aug 11
Investors Don't See Light At End Of Changjiang Pharmaceutical Group Co., Ltd.'s (SZSE:300391) Tunnel And Push Stock Down 31%

Changjiang Pharmaceutical Group Co., Ltd. (SZSE:300391) Looks Inexpensive After Falling 29% But Perhaps Not Attractive Enough

Jun 17
Changjiang Pharmaceutical Group Co., Ltd. (SZSE:300391) Looks Inexpensive After Falling 29% But Perhaps Not Attractive Enough

Changjiang Pharmaceutical Group Co., Ltd. (SZSE:300391) Looks Inexpensive After Falling 38% But Perhaps Not Attractive Enough

Apr 17
Changjiang Pharmaceutical Group Co., Ltd. (SZSE:300391) Looks Inexpensive After Falling 38% But Perhaps Not Attractive Enough

Changjiang Pharmaceutical Group Co., Ltd. (SZSE:300391) Not Doing Enough For Some Investors As Its Shares Slump 25%

Feb 27
Changjiang Pharmaceutical Group Co., Ltd. (SZSE:300391) Not Doing Enough For Some Investors As Its Shares Slump 25%

Aufschlüsselung der Einnahmen und Ausgaben

Wie Changjiang Pharmaceutical Group Geld verdient und ausgibt. Basierend auf den neuesten gemeldeten Einnahmen der letzten zwölf Monate.


Gewinn- und Umsatzhistorie

SZSE:300391 Einnahmen, Ausgaben und Erträge (CNY Millions)
DatumEinnahmenUmsatzAllgemeine und VerwaltungskostenF&E-Ausgaben
30 Sep 24277-6711805
30 Jun 24795-7343686
31 Mar 241,120-6303387
31 Dec 231,198-6063008
30 Sep 231,215-16723912
30 Jun 231,099-718811
31 Mar 231,207-6118120
01 Jan 231,615-2321326
30 Sep 221,966-2022333
30 Jun 222,056-7526139
31 Mar 222,122425937
01 Jan 222,3624924839
30 Sep 212,38812121341
30 Jun 212,14311717843
31 Mar 211,8749016646
31 Dec 201,2152514143
30 Sep 20784-69618846
30 Jun 20636-72318347
31 Mar 20591-70016344
31 Dec 19725-67017648
30 Sep 197632213637
30 Jun 198978113436
31 Mar 1998811514134
31 Dec 1888110212733
30 Sep 1894712314032
30 Jun 1889810311452
31 Mar 188298011344
31 Dec 177447010934
30 Sep 17564538329
30 Jun 1740935890
31 Mar 172415800
31 Dec 162354770
30 Sep 162146700
30 Jun 16194-1730
31 Mar 161954620
31 Dec 151915600
30 Sep 1521411640
30 Jun 1523121520
31 Mar 1524426540
31 Dec 1424329500
30 Sep 1425435470
30 Jun 1424834490
31 Mar 1425434500
31 Dec 1325535500

Qualität der Erträge: 300391 is currently unprofitable.

Wachsende Gewinnspanne: 300391 is currently unprofitable.


Analyse von freiem Cashflow und Gewinn


Analyse des Gewinnwachstums in der Vergangenheit

Ergebnisentwicklung: 300391 is unprofitable, and losses have increased over the past 5 years at a rate of 8% per year.

Beschleunigtes Wachstum: Unable to compare 300391's earnings growth over the past year to its 5-year average as it is currently unprofitable

Erträge im Vergleich zur Industrie: 300391 is unprofitable, making it difficult to compare its past year earnings growth to the Auto Components industry (10.1%).


Eigenkapitalrendite

Hohe Eigenkapitalrendite: 300391 has a negative Return on Equity (-115.28%), as it is currently unprofitable.


Kapitalrendite


Rendite auf das eingesetzte Kapital


Entdecken Sie starke Unternehmen, die in der Vergangenheit erfolgreich waren